In this study, we examined the autoimmune consequences of effective tumor vaccination on multiple organ systems and tested the impact of targeting the CD24-Siglec signaling pathway on both the vaccine therapy and autoimmune effects in the mouse neuroblastoma model. This evidence concerns the gene CD24 and neuroblastoma.